Tinsley Liane J, Kupelian Varant, D'Eon Stephanie A, Pober David, Sun Jennifer K, King George L, Keenan Hillary A
Section on Vascular Cell Biology, Joslin Diabetes Center, Boston, Massachusetts 02215.
Alexion Pharmaceuticals, Cambridge, Massachusetts 02139.
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3704-3711. doi: 10.1210/jc.2017-00589.
Previously we demonstrated, in individuals who have had type 1 diabetes (T1D) for 50 or more years (Medalists), that glycemic control was unrelated to diabetic complications, with the exception of cardiovascular disease (CVD), contrary to what has been documented in registry-based studies.
The purpose of this study is to validate these initial findings and identify contributors to mortality on an individual basis in a large cohort.
Cross-sectional and longitudinal study.
Joslin Diabetes Center (JDC), Boston, Massachusetts.
50-year Medalists presenting to JDC for study participation.
None.
Microvascular and macrovascular complications of diabetes and mortality.
Glycemic control was not significantly associated with small-vessel complications in Medalists but was associated with CVD in the overall cohort, yet with varying effect by tertile of cohort duration. CVD was the largest contributor to mortality, whereas hemoglobin A1c was not an independent predictor of mortality either overall or substantially by diagnosis interval. Additionally, exercise mitigated mortality risk imparted by CVD.
Few large populations with long duration of (T1D) have been available to examine the effects of long-term exposure to hyperglycemia. These data indicate that an association of glycemic control, complications, and mortality may change in an older population with T1D. These results suggest that careful control is still warranted in older populations with T1D.
此前我们在患有1型糖尿病(T1D)50年及以上的个体(“奖牌获得者”)中发现,血糖控制与糖尿病并发症无关,但心血管疾病(CVD)除外,这与基于登记研究的记录结果相反。
本研究旨在验证这些初步发现,并在一个大型队列中逐个确定死亡率的影响因素。
横断面和纵向研究。
马萨诸塞州波士顿的乔斯林糖尿病中心(JDC)。
前往JDC参与研究的50年病程“奖牌获得者”。
无。
糖尿病的微血管和大血管并发症及死亡率。
血糖控制与“奖牌获得者”的小血管并发症无显著关联,但与整个队列中的CVD相关,且因队列持续时间的三分位数而异其影响。CVD是死亡率的最大影响因素,而糖化血红蛋白无论是总体上还是按诊断间隔来看,都不是死亡率的独立预测因素。此外运动可减轻CVD带来的死亡风险。
很少有患T1D病程长且人数众多的群体可用于研究长期暴露于高血糖的影响。这些数据表明,在老年T1D人群中,血糖控制、并发症和死亡率之间可能发生变化。这些结果表明,对于老年T1D人群,仍有必要进行严格控制血糖。